MYD88 and neoplasm: Jia et al. reported that upregulated myeloid differentiation factor 88 (MyD88) may promote epithelial-mesenchymal transition (EMT) properties and tumor-initiating capabilities via the PI3K/Akt pathway, resulting in accelerated tumor growth and metastasis22.